Clinical trial

Exploring Mechanisms of Action in MDMA-assisted Psychotherapy for PTSD

Resilient PharmaceuticalsCompletedStarted Jan 1, 201410 enrolledUnited StatesNCT02102802

Abstract

The goal of this observational sub-study is to provide information on how MDMA-assisted therapy affects the brain and body of people with chronic PTSD. The main question it aims to answer is: Is PTSD symptom reduction associated with changes in heart rate variability and brain activity? Participants from the MP-8 study will be invited to enroll in this sub-study where they will undergo an fMRI brain scan and other measurements of body function.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

MDMAPTSD

Keywords

Brain activityfMRIHeart rate variabilityPhysiological correlatePosttraumatic Stress Disorder

View on registry

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.

Related research

ArticleMDMA

Aesthetic mediation and lateral agency: Rethinking trauma and drug consumption in 'crisis ordinariness'.

Fomiatti R, Keane H, Nourse G +4

Europe PMC2026

ArticlePsilocybin

Australia to prescribe MDMA and psilocybin for PTSD and depression in world first.

Haridy R

Europe PMC2023

PreprintMDMA

The Brinzei MDMA-PTSD Protocol: Addressing the Food and Drug Administration’s Breaking Blind Concerns with Precision Approaches to Post-Traumatic Stress Disorder Treatment

Brinzei O

Europe PMC2025